BUPRENORPHINE DOSIERUNGSSCHEMAS

Patent europeic · EP3215223 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3215223
Numer da la dumonda
EP15828368
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
06-11-2015
Publitgà
13-09-2017
Concedì
01-07-2020
La protecziun finescha il pli tard
05-11-2035
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61P 25/36 (2006.01)
A61P 25/04 (2006.01)
A61K 31/485 (2006.01)
Prioritad
US 201462076854 P 07.11.2014
US 201562100391 P 06.01.2015
US 201562112546 P 05.02.2015
US 201562199778 P 31.07.2015
Dumonda PCT
PCT/IB2015/002269 06.11.2015
Publicaziun PCT
WO2016/071767 12.05.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  4. 11-01-2023

    Midada

    Published in Swissreg on 11.01.2023

  5. 06-12-2022

    Midada

    Published in Swissreg on 06.12.2022

  6. 17-08-2022

    Midada

    Published in Swissreg on 17.08.2022

  7. 06-08-2020

    Represchentant inscrit

    Representative
    TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly

    Published in Swissreg on 06.08.2020

  8. 01-07-2020

    Concedì

    Published in Swissreg on 01.07.2020

Partidas

Inventur

NASSER, Azmi

Richmond, VA 23235, US

LAFFONT, Celine Marielle

North Chesterfield VA 23235, US

HEIDBREDER, Christian Arthur

North Chesterfield VA 23235, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.